Jaguar Health Insider Buying Surge Signals Confidence, But Risks Remain
Jaguar Health insider buying surge after a 25‑for‑1 reverse split signals leadership confidence amid a volatile biotech market, but investors weigh regulatory, reimbursement, and capital risks.
4 minutes to read